Related Experiment Videos
Early prenatal diagnosis of major congenital heart defects
1Brompton Fetal Cardiology, Royal Brompton Hospital and Fetal Medicine Unit, London, UK. j.carvalho@rbh.nthames.nhs.uk
Insights
Early fetal echocardiography, performed before 16 weeks, is a viable option for assessing congenital heart disease risk. This approach offers reassurance for many families by detecting major heart defects early in pregnancy.
Area of Science:
- Prenatal diagnosis
- Cardiology
- Medical imaging
Background:
- Specialized fetal echocardiography (18-22 weeks) is standard for detecting cardiac abnormalities.
- Growing interest in early fetal echocardiography (<16 weeks) for high-risk pregnancies.
- Advances in ultrasound technology enhance early-term scanning capabilities.
Purpose of the Study:
- To evaluate the feasibility and accuracy of early fetal echocardiography (<16 weeks) for congenital heart disease (CHD) screening.
- To assess the role of early screening in identifying high-risk groups.
- To compare early screening with mid-second trimester assessments.
Main Methods:
- Utilized modern transabdominal and transvaginal ultrasound technology.
- Focused on scanning between 11-14 weeks gestation, particularly in cases with increased nuchal translucency.
- Assessed the detection rates of major structural heart defects in the late first trimester.
Main Results:
- Early fetal echocardiography (<16 weeks) is feasible and accurate for diagnosing most major structural heart defects.
- Identified increased nuchal translucency as a marker for a high-risk group for cardiac abnormalities.
- Early scans can reassure families about normal cardiac development.
Conclusions:
- Early fetal echocardiography (<16 weeks) is a practical alternative for early CHD risk assessment.
- While early detection is possible, it does not replace mid-trimester scans due to potential lesion evolution.
- This approach aids in early identification and reassurance for at-risk pregnancies.
Abstract:
Specialized fetal echocardiography at 18 to 22 weeks for high-risk groups is well established as being sensitive and specific for most cardiac abnormalities. Early fetal echocardiography (< 16(+0) weeks, i.e. 16 weeks and 0 days) is a feasible alternative to mid second trimester scanning for families at risk of congenital heart disease. Two main areas have contributed to the increasing interest in first and early second trimester fetal echo. The recognition of the association between increased nuchal translucency and structural heart abnormalities has led to the identification of an important high-risk group at 11 to 14 weeks. Furthermore, the use of modern ultrasound technology has allowed greater utilization of transabdominal scanning in addition to the transvaginal route. Most major structural heart defects can accurately be diagnosed from the late first trimester of pregnancy and many families at-risk can be reassured of 'normality' of cardiac connections at an early stage. Some lesions may evolve throughout pregnancy and therefore early scans should not replace mid trimester fetal echocardiography.